Notch signaling and new therapeutic options in liver disease

Journal of Hepatology

Volumn 60, Issue 4, 2014, Pages 885-890

  Morell, Carola Maria ^a   Strazzabosco, Mario ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Liver cancer; Liver repair; Notch inhibitors; Notch signaling

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA; NOTCH RECEPTOR; TRANSCRIPTION FACTOR PDX 1;

ARTICLE; BILE DUCT CARCINOMA; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; ADULT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LIVER; LIVER DISEASES; LIVER NEOPLASMS; METABOLISM; TRANSLATIONAL RESEARCH;

ADULT; ANIMALS; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; LIVER REGENERATION; MODELS, BIOLOGICAL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84896398914     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.11.028     Document Type: Note

References (64)

1. M.E. Fortini Notch signaling: the core pathway and its posttranslational regulation Dev Cell 16 2009 633 647
2. S. Artavanis-Tsakonas, M.D. Rand, and R.J. Lake Notch signaling: cell fate control and signal integration in development Science 284 1999 770 776
3. S.J. Bray Notch signalling: a simple pathway becomes complex Nat Rev Mol Cell Biol 7 2006 678 689
4. R. Kopan, and M.X. Ilagan The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 2009 216 233
5. E.C. Lai Notch signaling: control of cell communication and cell fate Development 131 2004 965 973
6. C. Coffinier, L. Gresh, L. Fiette, F. Tronche, G. Schutz, and C. Babinet et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1β Development 129 2002 1829 1838
7. Y. Kodama, M. Hijikata, R. Kageyama, K. Shimotohno, and T. Chiba The role of notch signaling in the development of intrahepatic bile ducts Gastroenterology 127 2004 1775 1786
8. Y. Zong, A. Panikkar, J. Xu, A. Antoniou, P. Raynaud, and F. Lemaigre et al. Notch signaling controls liver development by regulating biliary differentiation Development 136 2009 1727 1739
9. C.M. Morell, R. Fiorotto, L. Fabris, and M. Strazzabosco Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis Clin Res Hepatol Gastroenterol 37 2013 447 454
10. A. Antoniou, P. Raynaud, S. Cordi, Y. Zong, F. Tronche, and B.Z. Stanger et al. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9 Gastroenterology 136 2009 2325 2333
11. F. Geisler, F. Nagl, P.K. Mazur, M. Lee, U. Zimber-Strobl, and L.J. Strobl et al. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice Hepatology 48 2008 607 616
12. J.J. Hofmann, A.C. Zovein, H. Koh, F. Radtke, G. Weinmaster, and M.L. Iruela-Arispe Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome Development 137 2010 4061 4072
13. K.M. Loomes, P. Russo, M. Ryan, A. Nelson, L. Underkoffler, and C. Glover et al. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage Hepatology 45 2007 323 330
14. J. Lozier, B. McCright, and T. Gridley Notch signaling regulates bile duct morphogenesis in mice PLoS One 3 2008 e1851
15. B. McCright, J. Lozier, and T. Gridley A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency Development 129 2002 1075 1082
16. E.E. Sparks, K.A. Huppert, M.A. Brown, M.K. Washington, and S.S. Huppert Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice Hepatology 51 2010 1391 1400
17. L. Li, I.D. Krantz, Y. Deng, A. Genin, A.B. Banta, and C.C. Collins et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 Nat Genet 16 1997 243 251
18. T. Oda, A.G. Elkahloun, B.L. Pike, K. Okajima, I.D. Krantz, and A. Genin et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome Nat Genet 16 1997 235 242
19. R. McDaniell, D.M. Warthen, P.A. Sanchez-Lara, A. Pai, I.D. Krantz, and D.A. Piccoli et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway Am J Hum Genet 79 2006 169 173
20. I. Espinoza, and L. Miele Notch inhibitors for cancer treatment Pharmacol Ther 139 2013 95 110
21. C. Groth, and M.E. Fortini Therapeutic approaches to modulating Notch signaling: current challenges and future prospects Semin Cell Dev Biol 23 2012 465 472
22. L. Fabris, M. Cadamuro, M. Guido, C. Spirli, R. Fiorotto, and M. Colledan et al. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling Am J Pathol 171 2007 641 653
23. K.N. Lazaridis, M. Strazzabosco, and N.F. Larusso The cholangiopathies: disorders of biliary epithelia Gastroenterology 127 2004 1565 1577
24. M. Strazzabosco, L. Fabris, and C. Spirli Pathophysiology of cholangiopathies J Clin Gastroenterol 39 2005 S90 S102
25. L. Boulter, O. Govaere, T.G. Bird, S. Radulescu, P. Ramachandran, and A. Pellicoro et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease Nat Med 18 2012 572 579
26. G. Xie, G. Karaca, M. Swiderska-Syn, G.A. Michelotti, L. Kruger, and Y. Chen Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice Hepatology 2013 [Epub ahead of print]
27. M. Marzioni, S. Saccomanno, L. Agostinelli, C. Rychlicki, S. De Minicis, and I. Pierantonelli et al. PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis J Hepatol 58 2013 750 756
28. R. Fiorotto, A. Raizner, C.M. Morell, B. Torsello, R. Scirpo, and L. Fabris et al. Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice J Hepatol 59 2013 124 130
29. B. Spee, G. Carpino, B.A. Schotanus, A. Katoonizadeh, S. Vander Borght, and E. Gaudio et al. Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling Gut 59 2010 247 257
30. S.S. Nijjar, H.A. Crosby, L. Wallace, S.G. Hubscher, and A.J. Strain Notch receptor expression in adult human liver: a possible role in bile duct formation and hepatic neovascularization Hepatology 34 2001 1184 1192
31. Y. Chen, S. Zheng, D. Qi, S. Zheng, J. Guo, and S. Zhang et al. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats PLoS One 7 2012 e46512
32. I. Sawitza, C. Kordes, S. Reister, and D. Haussinger The niche of stellate cells within rat liver Hepatology 50 2009 1617 1624
33. S.S. Nijjar, L. Wallace, H.A. Crosby, S.G. Hubscher, and A.J. Strain Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects Am J Pathol 160 2002 1695 1703
34. S. Tsai, A. Gurakar, R. Anders, D. Lam-Himlin, J. Boitnott, and T.M. Pawlik Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature Dig Dis Sci 55 2010 3052 3058
35. Z.D. Burke, K.R. Reed, T.J. Phesse, O.J. Sansom, A.R. Clarke, and D. Tosh Liver zonation occurs through a β-catenin-dependent, c-Myc-independent mechanism Gastroenterology 136 2009 e2311 e2313
36. N. Tanimizu, and A. Miyajima Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors J Cell Sci 117 2004 3165 3174
37. K. Yanger, Y. Zong, L.R. Maggs, S.N. Shapira, R. Maddipati, and N.M. Aiello et al. Robust cellular reprogramming occurs spontaneously during liver regeneration Genes Dev 27 2013 719 724
38. B. Fan, Y. Malato, D.F. Calvisi, S. Naqvi, N. Razumilava, and S. Ribback et al. Cholangiocarcinomas can originate from hepatocytes in mice J Clin Invest 122 2012 2911 2915
39. S. Sekiya, and A. Suzuki Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes J Clin Invest 122 2012 3914 3918
40. D. Alvaro, M.C. Bragazzi, A. Benedetti, L. Fabris, G. Fava, and P. Invernizzi et al. Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease Dig Liver Dis 43 2011 60 65
41. W.C. Palmer, and T. Patel Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma J Hepatol 57 2012 69 76
42. J.S. Lee, J. Heo, L. Libbrecht, I.S. Chu, P. Kaposi-Novak, and D.F. Calvisi et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
43. M. Komuta, O. Govaere, V. Vandecaveye, J. Akiba, W. Van Steenbergen, and C. Verslype et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes Hepatology 55 2012 1876 1888
44. A.P. Weng, A.A. Ferrando, W. Lee, J.P. Morris, L.B. Silverman, and C. Sanchez-Irizarry et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia Science 306 2004 269 271
45. P. Ranganathan, K.L. Weaver, and A.J. Capobianco Notch signalling in solid tumours: a little bit of everything but not all the time Nat Rev Cancer 11 2011 338 351
46. C. Kohler, A.W. Bell, W.C. Bowen, S.P. Monga, W. Fleig, and G.K. Michalopoulos Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration Hepatology 39 2004 1056 1065
47. A. Croquelois, A. Blindenbacher, L. Terracciano, X. Wang, I. Langer, and F. Radtke et al. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice Hepatology 41 2005 487 496
48. M.A. Nalesnik, G. Tseng, Y. Ding, G.S. Xiang, Z.L. Zheng, and Y. Yu et al. Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation Am J Pathol 180 2012 1495 1508
49. M. Strazzabosco, and L. Fabris Notch signaling in hepatocellular carcinoma: guilty in association! Gastroenterology 143 2012 1430 1434
50. A. Villanueva, C. Alsinet, K. Yanger, Y. Hoshida, Y. Zong, and S. Toffanin et al. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice Gastroenterology 143 2012 e1667
51. M.T. Dill, L. Tornillo, T. Fritzius, L. Terracciano, D. Semela, and B. Bettler et al. Constitutive Notch2 signaling induces hepatic tumors in mice Hepatology 57 2012 1607 1619
52. C. Sempoux, G. Jibara, S.C. Ward, C. Fan, L. Qin, and S. Roayaie et al. Intrahepatic cholangiocarcinoma: new insights in pathology Semin Liver Dis 31 2011 49 60
53. N. Ishimura, S.F. Bronk, and G.J. Gores Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis Gastroenterology 128 2005 1354 1368
54. J.H. van Es, M.E. van Gijn, O. Riccio, M. van den Born, M. Vooijs, and H. Begthel et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells Nature 435 2005 959 963
55. S. Zender, I. Nickeleit, T. Wuestefeld, I. Sorensen, D. Dauch, and P. Bozko et al. A critical role for notch signaling in the formation of cholangiocellular carcinomas Cancer Cell 23 2013 784 795
56. M. Aste-Amezaga, N. Zhang, J.E. Lineberger, B.A. Arnold, T.J. Toner, and M. Gu et al. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors PLoS One 5 2010 e9094
57. Y. Wu, C. Cain-Hom, L. Choy, T.J. Hagenbeek, G.P. de Leon, and Y. Chen et al. Therapeutic antibody targeting of individual Notch receptors Nature 464 2010 1052 1057
58. K. Li, Y. Li, W. Wu, W.R. Gordon, D.W. Chang, and M. Lu et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3 J Biol Chem 283 2008 8046 8054
59. J. Ridgway, G. Zhang, Y. Wu, S. Stawicki, W.C. Liang, and Y. Chanthery et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis Nature 444 2006 1083 1087
60. Y. Funahashi, S.L. Hernandez, I. Das, A. Ahn, J. Huang, and M. Vorontchikhina et al. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis Cancer Res 68 2008 4727 4735
61. B. Varnum-Finney, L. Wu, M. Yu, C. Brashem-Stein, S. Staats, and D. Flowers et al. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling J Cell Sci 113 2000 4313 4318
62. D. Small, D. Kovalenko, D. Kacer, L. Liaw, M. Landriscina, and C. Di Serio et al. Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype J Biol Chem 276 2001 32022 32030
63. E.R. Siemers, J.F. Quinn, J. Kaye, M.R. Farlow, A. Porsteinsson, and P. Tariot et al. Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease Neurology 66 2006 602 604
64. I. Hayashi, S. Takatori, Y. Urano, Y. Miyake, J. Takagi, and M. Sakata-Yanagimoto et al. Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin Oncogene 31 2012 787 798